Address	100 Technology Center Drive Stoughton Massachusetts 02072 United States
Employees	-
Website	http://www.collegiumpharma.com
Updated	07/08/2019
Collegium Pharmaceutical, Inc. engages in the development and commercialization of next-generation, abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. Its products include Xtampza ER, and ONSOLIS. Xtampza ER provides pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse.